JP2015500883A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500883A5
JP2015500883A5 JP2014548851A JP2014548851A JP2015500883A5 JP 2015500883 A5 JP2015500883 A5 JP 2015500883A5 JP 2014548851 A JP2014548851 A JP 2014548851A JP 2014548851 A JP2014548851 A JP 2014548851A JP 2015500883 A5 JP2015500883 A5 JP 2015500883A5
Authority
JP
Japan
Prior art keywords
alkyl
group
alkoxy
compound according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014548851A
Other languages
English (en)
Japanese (ja)
Other versions
JP6132851B2 (ja
JP2015500883A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/070710 external-priority patent/WO2013096501A1/en
Publication of JP2015500883A publication Critical patent/JP2015500883A/ja
Publication of JP2015500883A5 publication Critical patent/JP2015500883A5/ja
Application granted granted Critical
Publication of JP6132851B2 publication Critical patent/JP6132851B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014548851A 2011-12-21 2012-12-19 一般的な抗炎症反応を与える複数のプロスタグランジン受容体において作用する化合物 Active JP6132851B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161578456P 2011-12-21 2011-12-21
US61/578,456 2011-12-21
PCT/US2012/070710 WO2013096501A1 (en) 2011-12-21 2012-12-19 Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response

Publications (3)

Publication Number Publication Date
JP2015500883A JP2015500883A (ja) 2015-01-08
JP2015500883A5 true JP2015500883A5 (enExample) 2016-02-18
JP6132851B2 JP6132851B2 (ja) 2017-05-24

Family

ID=47436296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014548851A Active JP6132851B2 (ja) 2011-12-21 2012-12-19 一般的な抗炎症反応を与える複数のプロスタグランジン受容体において作用する化合物

Country Status (6)

Country Link
US (1) US8969589B2 (enExample)
EP (1) EP2794574B1 (enExample)
JP (1) JP6132851B2 (enExample)
AU (1) AU2012358983B2 (enExample)
CA (1) CA2860392C (enExample)
WO (1) WO2013096501A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106146400A (zh) * 2015-03-20 2016-11-23 四川大学 苄基-1h-吡唑、苄基-1h-吡咯衍生物及其制备方法和用途
US9827225B2 (en) 2016-01-25 2017-11-28 Jenivision Inc. Use of prostacyclin antagonists for treating ocular surface nociception
WO2017153231A1 (de) * 2016-03-09 2017-09-14 Bayer Pharma Aktiengesellschaft Substituierte n-cyclo-2-arylisochinolinon-4-carboxamide und ihre verwendung
WO2017153234A1 (de) * 2016-03-09 2017-09-14 Bayer Pharma Aktiengesellschaft Substituierte n-cyclo-2-arylchinolin-4-carboxamide und ihre verwendung
TW202228674A (zh) 2020-11-13 2022-08-01 日商小野藥品工業股份有限公司 藉由併用ｅｐ４拮抗藥與免疫檢查點抑制物質而進行之癌症治療
CN118184646A (zh) * 2024-05-14 2024-06-14 苏州弘道新材料有限公司 用于光伏胶膜的吡唑啉衍生物光转换材料及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US7217725B2 (en) 2000-09-14 2007-05-15 Allergan, Inc. Prostaglandin D2 antagonist
US7273883B2 (en) 2000-09-14 2007-09-25 Allergan, Inc. Prostaglandin EP4 antagonist
US6511999B2 (en) 2000-09-14 2003-01-28 Allergan, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
ES2298832T3 (es) * 2003-10-24 2008-05-16 Glaxo Group Limited Compuestos heterociclicos.
GB0508472D0 (en) * 2005-04-26 2005-06-01 Glaxo Group Ltd Compounds
US8492424B2 (en) * 2010-07-01 2013-07-23 Allergan, Inc. Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response

Similar Documents

Publication Publication Date Title
JP2015500883A5 (enExample)
JP2013535424A5 (enExample)
JP2018535967A5 (enExample)
EA201100423A1 (ru) Новые бензамиды, их получение и их применение в качестве лекарственных средств
JP2017530959A5 (enExample)
JP2015504909A5 (enExample)
EA201200876A1 (ru) Новые антагонисты рецептора ccr2 и их применение
JP2020532547A5 (enExample)
JP2019535761A5 (enExample)
JP2010516788A (ja) チオピリミジンベースの化合物およびその使用
JP2012255002A5 (enExample)
RU2011147374A (ru) Диамидные соединения, обладающие активностью антагониста мускаринового рецептора и активностью агониста в2 адренергического рецептора
JP2017510624A5 (enExample)
CN1048239C (zh) 萘衍生物
CA2656057A1 (en) Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
JP2008505171A5 (enExample)
CN1555356A (zh) 作为nhe-3抑制剂的双酚衍生物
EA200600853A1 (ru) Новый кристаллический ангидрат с антихолинергическим действием
RU2019121673A (ru) Активаторы nrf2
JP2011503072A5 (enExample)
JP2015503562A5 (enExample)
RU2011124149A (ru) Нафтилуксусные кислоты
JP2014511897A5 (enExample)
JP2012501334A5 (enExample)
TWI469965B (zh) 乙炔基吲哚化合物